- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-06-0010646

About Nordea Lifescience Private Limited
Data last updated:
Nordea Lifescience Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 July 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2004PTC127933. Its GSTIN is 07AABCN9557D1ZC (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sunaina Jain and Kuldeep Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 175 Vardhman Grand Plaza Plot No. 7 Mangalam Place Sector – 3 Rohini New De, Lhi – 110085, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.38 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹9.99 Lakh (net margin 4.2%) and EBITDA of ₹12.97 Lakh (EBITDA margin 5.5%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 46% over five years.
Nordea Lifescience Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0010646). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nordealifescience.com.
Company details
Recognitions & Rankings of Nordea Lifescience
Contact details
Nordea Lifescience Private Limited's registered office is in Delhi, Delhi. Its website is nordealifescience.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address175 Vardhman Grand Plaza Plot No. 7 Mangalam Place Sector – 3 Rohini New De, Lhi – 110085, Delhi, India – 110085
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Nordea Lifescience Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nordea Lifescience is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nordea Lifescience Private Limited, buy the company report.
Financials of Nordea Lifescience Private Limited
FY 2025 filings availableNordea Lifescience Private Limited reported revenue of ₹2.38 Cr (up 207% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 46% over five years, including 207% growth in the latest year. EBITDA rose 402% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.97 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.99 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.5% | ||||
| Net Profit Margin | 4.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nordea Lifescience Private Limited, buy the company report.
Board of directors of Nordea Lifescience Private Limited
Nordea Lifescience has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunaina Jain Also directs: Orange Pharma Private Limited | Director | 11 Aug 2008 | 18 Years 3 Months | Current |
| Kuldeep Jain Also directs: Orange Pharma Private Limited, Sara Biotique Private Limited | Director | 28 Jul 2004 | 22 Years 3 Months | Current |
Auditor
Nordea Lifescience Private Limited is audited by MANISH S GOEL & ASSOCIATES for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANISH S GOEL & ASSOCIATES | FY 2016 | 019894N |
Shareholding
The shareholding of Nordea Lifescience Private Limited is on record for 2 financial years, the latest being FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 | FY 2015 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Nordea Lifescience Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nordea Lifescience Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nordea Lifescience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nordea Lifescience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCN9557D1ZC | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nordea Lifescience Private Limited, buy the company report.
Recent activity
Nordea Lifescience Private Limited has 4 board changes on record since 2004: 2 appointments and 2 cessations. The latest: Rajeev Jain ceased to be Director on 12 Aug 2009.
Frequently asked questions
Nordea Lifescience is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 July 2004 (22+ years old) and is registered under CIN U24232DL2004PTC127933.
Nordea Lifescience has 2 current directors:
- Sunaina Jain - Director
- Kuldeep Jain - Director
The latest financial statements of Nordea Lifescience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nordea Lifescience is 07AABCN9557D1ZC, registered in Delhi.
The CIN (Corporate Identification Number) of Nordea Lifescience is U24232DL2004PTC127933. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nordea Lifescience was incorporated on 28 July 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.
Rajeev Jain ceased to be Director on 12 Aug 2009. Sunaina Jain ceased to be Additional Director on 30 Sep 2008. Sunaina Jain was appointed as Director on 11 Aug 2008. Nordea Lifescience has 4 board changes on record in total.
Yes, Nordea Lifescience is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-06-0010646).
Nordea Lifescience can be reached through the website nordealifescience.com. Its registered office is in Delhi, India.
The registered office of Nordea Lifescience is at 175 Vardhman Grand Plaza Plot No. 7 Mangalam Place Sector – 3 Rohini New De, Lhi – 110085, Delhi, India – 110085.

